Utilizing melatonin to combat bacterial infections and septic injury

Wei Hu, Chao Deng, Zhiqiang Ma, Dongjin Wang, Chongxi Fan, Tian Li, Shouyin Di, Bing Gong, Russel J Reiter, Yang Yang

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Melatonin, also known as N-acetyl-5-methoxytryptamine, is a ubiquitously acting molecule that is produced by the pineal gland and other organs of animals, including humans. As melatonin and its metabolites are potent antioxidants and free radical scavengers, they are protective against a variety of disorders. Moreover, multiple molecular targets of melatonin have been identified, and its actions are both receptor-mediated and receptor-independent. Recent studies have shown that melatonin may be useful in fighting against sepsis and septic injury due to its antioxidative and anti-inflammatory actions; the results generally indicate a promising therapeutic application for melatonin in the treatment of sepsis. To provide a comprehensive understanding regarding the protective effects of melatonin against septic injury, in the present review we have evaluated the published literature in which melatonin has been used to treat experimental and clinical sepsis. Firstly, we present the evidence from studies that have used melatonin to resist bacterial pathogens. Secondly, we illustrate the protective effect of melatonin against septic injury and discuss the possible mechanisms. Finally, the potential directions for future melatonin research against sepsis are summarized.

Original languageEnglish (US)
Pages (from-to)754-768
Number of pages15
JournalBritish Journal of Pharmacology
Volume174
Issue number9
DOIs
StatePublished - May 1 2017

Fingerprint

Melatonin
Bacterial Infections
Wounds and Injuries
Sepsis
5-Methoxytryptamine
Animal Structures
Free Radical Scavengers
Pineal Gland
Anti-Inflammatory Agents
Antioxidants

ASJC Scopus subject areas

  • Pharmacology

Cite this

Hu, W., Deng, C., Ma, Z., Wang, D., Fan, C., Li, T., ... Yang, Y. (2017). Utilizing melatonin to combat bacterial infections and septic injury. British Journal of Pharmacology, 174(9), 754-768. https://doi.org/10.1111/bph.13751

Utilizing melatonin to combat bacterial infections and septic injury. / Hu, Wei; Deng, Chao; Ma, Zhiqiang; Wang, Dongjin; Fan, Chongxi; Li, Tian; Di, Shouyin; Gong, Bing; Reiter, Russel J; Yang, Yang.

In: British Journal of Pharmacology, Vol. 174, No. 9, 01.05.2017, p. 754-768.

Research output: Contribution to journalReview article

Hu, W, Deng, C, Ma, Z, Wang, D, Fan, C, Li, T, Di, S, Gong, B, Reiter, RJ & Yang, Y 2017, 'Utilizing melatonin to combat bacterial infections and septic injury', British Journal of Pharmacology, vol. 174, no. 9, pp. 754-768. https://doi.org/10.1111/bph.13751
Hu, Wei ; Deng, Chao ; Ma, Zhiqiang ; Wang, Dongjin ; Fan, Chongxi ; Li, Tian ; Di, Shouyin ; Gong, Bing ; Reiter, Russel J ; Yang, Yang. / Utilizing melatonin to combat bacterial infections and septic injury. In: British Journal of Pharmacology. 2017 ; Vol. 174, No. 9. pp. 754-768.
@article{b7cdaca854bf4b8ea08b40a9d4d3b18b,
title = "Utilizing melatonin to combat bacterial infections and septic injury",
abstract = "Melatonin, also known as N-acetyl-5-methoxytryptamine, is a ubiquitously acting molecule that is produced by the pineal gland and other organs of animals, including humans. As melatonin and its metabolites are potent antioxidants and free radical scavengers, they are protective against a variety of disorders. Moreover, multiple molecular targets of melatonin have been identified, and its actions are both receptor-mediated and receptor-independent. Recent studies have shown that melatonin may be useful in fighting against sepsis and septic injury due to its antioxidative and anti-inflammatory actions; the results generally indicate a promising therapeutic application for melatonin in the treatment of sepsis. To provide a comprehensive understanding regarding the protective effects of melatonin against septic injury, in the present review we have evaluated the published literature in which melatonin has been used to treat experimental and clinical sepsis. Firstly, we present the evidence from studies that have used melatonin to resist bacterial pathogens. Secondly, we illustrate the protective effect of melatonin against septic injury and discuss the possible mechanisms. Finally, the potential directions for future melatonin research against sepsis are summarized.",
author = "Wei Hu and Chao Deng and Zhiqiang Ma and Dongjin Wang and Chongxi Fan and Tian Li and Shouyin Di and Bing Gong and Reiter, {Russel J} and Yang Yang",
year = "2017",
month = "5",
day = "1",
doi = "10.1111/bph.13751",
language = "English (US)",
volume = "174",
pages = "754--768",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Utilizing melatonin to combat bacterial infections and septic injury

AU - Hu, Wei

AU - Deng, Chao

AU - Ma, Zhiqiang

AU - Wang, Dongjin

AU - Fan, Chongxi

AU - Li, Tian

AU - Di, Shouyin

AU - Gong, Bing

AU - Reiter, Russel J

AU - Yang, Yang

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Melatonin, also known as N-acetyl-5-methoxytryptamine, is a ubiquitously acting molecule that is produced by the pineal gland and other organs of animals, including humans. As melatonin and its metabolites are potent antioxidants and free radical scavengers, they are protective against a variety of disorders. Moreover, multiple molecular targets of melatonin have been identified, and its actions are both receptor-mediated and receptor-independent. Recent studies have shown that melatonin may be useful in fighting against sepsis and septic injury due to its antioxidative and anti-inflammatory actions; the results generally indicate a promising therapeutic application for melatonin in the treatment of sepsis. To provide a comprehensive understanding regarding the protective effects of melatonin against septic injury, in the present review we have evaluated the published literature in which melatonin has been used to treat experimental and clinical sepsis. Firstly, we present the evidence from studies that have used melatonin to resist bacterial pathogens. Secondly, we illustrate the protective effect of melatonin against septic injury and discuss the possible mechanisms. Finally, the potential directions for future melatonin research against sepsis are summarized.

AB - Melatonin, also known as N-acetyl-5-methoxytryptamine, is a ubiquitously acting molecule that is produced by the pineal gland and other organs of animals, including humans. As melatonin and its metabolites are potent antioxidants and free radical scavengers, they are protective against a variety of disorders. Moreover, multiple molecular targets of melatonin have been identified, and its actions are both receptor-mediated and receptor-independent. Recent studies have shown that melatonin may be useful in fighting against sepsis and septic injury due to its antioxidative and anti-inflammatory actions; the results generally indicate a promising therapeutic application for melatonin in the treatment of sepsis. To provide a comprehensive understanding regarding the protective effects of melatonin against septic injury, in the present review we have evaluated the published literature in which melatonin has been used to treat experimental and clinical sepsis. Firstly, we present the evidence from studies that have used melatonin to resist bacterial pathogens. Secondly, we illustrate the protective effect of melatonin against septic injury and discuss the possible mechanisms. Finally, the potential directions for future melatonin research against sepsis are summarized.

UR - http://www.scopus.com/inward/record.url?scp=85016403993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016403993&partnerID=8YFLogxK

U2 - 10.1111/bph.13751

DO - 10.1111/bph.13751

M3 - Review article

C2 - 28213968

AN - SCOPUS:85016403993

VL - 174

SP - 754

EP - 768

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 9

ER -